Near Term Goals for Lab-Grown Leather

In this interview, Dr. Che Connon explains how BSF Enterprise is developing lab-grown leather using its proprietary tissue engineering platform.

He outlines how the Company grows real skin from cells in the laboratory, allowing those cells to produce the structural components responsible for leather’s strength, durability, ageing and feel. Unlike alternative approaches, BSF does not use scaffolding — meaning the material closely replicates the performance characteristics of traditional animal leather.

The discussion also highlights how controlling the biology enables entirely new material possibilities, including:

• A “technical leather” that is up to ten times thinner and lighter than conventional leather, while retaining comparable strength

• The ability to genetically engineer cells to create novel materials

• The development of the world’s first Tyrannosaurus Rex leather, derived from DNA sequences reconstructed from fossilised peptides

Dr. Connon explains that production is currently at laboratory scale, with materials supplied to luxury brands for testing.

The interview also outlines near-term objectives:

• Scaling production

• Securing strategic luxury partnerships

• Launching the first commercial T-Rex leather product

• Licensing the technology to enable partner-led manufacturing

This video provides investors with insight into BSF’s strategy to industrialise tissue engineering and redefine the future of leather.